Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort [PDF]
, 2017 Aims: To examine the number and type of co-morbid long-term health conditions (LTCs) and their associations with all-cause mortality in an atrial fibrillation (AF) population.
Connelly, Derek T. +7 more
core +1 more source
Multimorbidity in bipolar disorder and under-treatment of cardiovascular disease: a cross sectional study [PDF]
, 2013 Background: Individuals with serious mental disorders experience poor physical health, especially increased rates of cardiometabolic morbidity and premature morbidity.
A Weeke +42 more
core +3 more sources
Multimorbidity patterns and association with mortality in 0.5 million Chinese adults
Chinese Medical Journal, 2022 . Background:. Few studies have assessed the relationship between multimorbidity patterns and mortality risk in the Chinese population. We aimed to identify multimorbidity patterns and examined the associations of multimorbidity patterns and the number ...
Junning Fan +18 more
doaj +1 more source
Relationship of depression screening in cardiometabolic disease with vascular events and mortality: findings from a large primary care cohort with 4 years follow-up [PDF]
, 2016 Aims: Benefits of routine depression screening for cardiometabolic disease patients remain unclear. We examined the association between depression screening and all-cause mortality and vascular events in cardiometabolic disease patients.
Barry, Sarah J.E. +5 more
core +1 more source
Relationship between blood pressure values, depressive symptoms and cardiovascular outcomes in patients with cardiometabolic disease [PDF]
, 2016 We studied joint effect of blood pressure-BP and depression on risk of major adverse cardiovascular outcome in patients with existing cardiometabolic disease. A cohort of 35537 patients with coronary heart disease, diabetes or stroke underwent depression
Barry, Sarah J.E. +5 more
core +2 more sources
Measuring the burden of treatment for chronic disease: implications of a scoping review of the literature [PDF]
, 2017 Background: Although there has been growing research on the burden of treatment, the current state of evidence on measuring this concept is unknown.
Mair, Frances S. +3 more
core +3 more sources
Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada. [PDF]
, 2020 IntroductionWeight gain following antiretroviral therapy (ART) initiation is common, potentially predisposing some persons with HIV (PWH) to cardio-metabolic disease.
Altoff, Keri N +23 more
core +1 more source
Medication burden in the first 5 years following diagnosis of type 2 diabetes: findings from the ADDITION-UK trial cohort. [PDF]
, 2015 INTRODUCTION: Individuals with screen-detected diabetes are likely to receive intensified pharmacotherapy to improve glycaemic control and general cardiometabolic health.
Black, James A +7 more
core +2 more sources
BMJ Open, 2023 Objective To determine the patterns of cardiometabolic multimorbidity and associated risk factors in sub-Saharan Africa (SSA).Design We used data from the WHO STEPwise approach to non-communicable disease risk factor surveillance cross-sectional surveys ...
Charles Agyemang +6 more
doaj +1 more source
Prevalence and correlates of frailty in an older rural African population:findings from the HAALSI cohort study [PDF]
, 2017 Background: Frailty is a key predictor of death and dependency, yet little is known about frailty in sub-Saharan Africa despite rapid population ageing. We describe the prevalence and correlates of phenotypic frailty using data from the Health and Aging ...
A Clegg +32 more
core +4 more sources